Description
Identification of gene mutations that increase risk of cancer or has therapeutic implications in an affected individual
OncQuer TM Germline Mutation Panel by NGS
Identification of gene mutations that increase risk of cancer or has therapeutic implications in an affected individual
TAT:
Specimen Type:
Genomics Panel Test
Other Tests
-
264%
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM Scout LB EGFR Response Test
Identification gene mutations leading to sensitivity and resistance to EGFR therapy
OncQuer TM Scout LB EGFR Response Test
Identification gene mutations leading to sensitivity and resistance to EGFR therapy
-
264%
OncQuer TM Myeloid Panel (1-3 markers)
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Myeloid Panel (1-3 markers)
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
Reviews
There are no reviews yet.